引言：HIV中和抗体：与发病机制及疫苗的相关性 - Suppr

Suppr

超能文献

Introduction: HIV neutralizing antibodies: relevance to pathogenesis and vaccines.

作者信息

Albert J, Chiodi F, Fenyö E M

机构信息

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.

出版信息

J Intern Med. 2007 Jul;262(1):2-4. doi: 10.1111/j.1365-2796.2007.01835.x.

DOI:10.1111/j.1365-2796.2007.01835.x

PMID:17598811

Abstract

摘要

相似文献

Introduction: HIV neutralizing antibodies: relevance to pathogenesis and vaccines.

J Intern Med. 2007 Jul;262(1):2-4. doi: 10.1111/j.1365-2796.2007.01835.x.

HIV vaccine development--improving on natural immunity.

N Engl J Med. 2011 Sep 8;365(10):873-5. doi: 10.1056/NEJMp1107621.

Genetic and immune correlates of the HIV infection and vaccine-induced immunity. Foreword.

Vaccine. 2008 Jun 6;26(24):2949-50. doi: 10.1016/j.vaccine.2008.02.003. Epub 2008 Feb 13.

HIV/AIDS: allied responses.

Nature. 2007 Sep 6;449(7158):29-30. doi: 10.1038/449029a.

Neutralizing antibodies take a swipe at HIV in vivo.

Nat Med. 2005 Jun;11(6):593-4. doi: 10.1038/nm0605-593.

Support for the RV144 HIV vaccine trial.

Science. 2004 Jul 9;305(5681):177-80; author reply 177-80. doi: 10.1126/science.305.5681.177b.

Selection of human anti-HIV broadly neutralizing antibodies occurs within the context of frozen 1F7-idiotypic repertoire.

AIDS. 2011 Jun 19;25(10):1249-64. doi: 10.1097/QAD.0b013e328347f9fa.

The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity.

AIDS. 1999;13 Suppl A:S137-62.

B cell immunopathology during HIV-1 infection: lessons to learn for HIV-1 vaccine design.

Vaccine. 2008 Jun 6;26(24):3016-25. doi: 10.1016/j.vaccine.2007.11.063. Epub 2007 Dec 17.

HIV. Escape artist par excellence.

Science. 2003 Mar 7;299(5612):1505-8. doi: 10.1126/science.299.5612.1505.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Introduction: HIV neutralizing antibodies: relevance to pathogenesis and vaccines.

J Intern Med. 2007 Jul;262(1):2-4. doi: 10.1111/j.1365-2796.2007.01835.x.

HIV vaccine development--improving on natural immunity.

N Engl J Med. 2011 Sep 8;365(10):873-5. doi: 10.1056/NEJMp1107621.

Genetic and immune correlates of the HIV infection and vaccine-induced immunity. Foreword.

Vaccine. 2008 Jun 6;26(24):2949-50. doi: 10.1016/j.vaccine.2008.02.003. Epub 2008 Feb 13.

HIV/AIDS: allied responses.

Nature. 2007 Sep 6;449(7158):29-30. doi: 10.1038/449029a.

Neutralizing antibodies take a swipe at HIV in vivo.

Nat Med. 2005 Jun;11(6):593-4. doi: 10.1038/nm0605-593.

Support for the RV144 HIV vaccine trial.

Science. 2004 Jul 9;305(5681):177-80; author reply 177-80. doi: 10.1126/science.305.5681.177b.

Selection of human anti-HIV broadly neutralizing antibodies occurs within the context of frozen 1F7-idiotypic repertoire.

AIDS. 2011 Jun 19;25(10):1249-64. doi: 10.1097/QAD.0b013e328347f9fa.

The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity.

AIDS. 1999;13 Suppl A:S137-62.

B cell immunopathology during HIV-1 infection: lessons to learn for HIV-1 vaccine design.

Vaccine. 2008 Jun 6;26(24):3016-25. doi: 10.1016/j.vaccine.2007.11.063. Epub 2007 Dec 17.

HIV. Escape artist par excellence.

Science. 2003 Mar 7;299(5612):1505-8. doi: 10.1126/science.299.5612.1505.